Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous cell-free fat extract (ACFE) is a bioactive liquid biologic derived from a patient's own adipose tissue through mechanical emulsification and centrifugation, followed by filtration to remove cellular components. Developed by researchers at the Shanghai Ninth People's Hospital, ACFE is rich in endogenous growth factors (such as VEGF, HGF, and IGF-1) and cytokines that promote angiogenesis, reduce inflammation, and stimulate hair follicle regeneration. It is primarily investigated for the treatment of androgenetic alopecia and alopecia areata, where it is administered via local intradermal injection to rejuvenate the scalp microenvironment and activate dormant hair follicles. The extract works by delivering a concentrated cocktail of regenerative proteins that modulate signaling pathways like Wnt/beta-catenin to promote tissue repair and hair growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous cell-free fat extract.